Baidu
map

医生才是互联网+医疗江湖中“大佬”

2015-09-16 佚名 新京报

当今的互联网+创业潮中,风头正盛的,不得不说是医生集团。 一些医生集团的创始者,人还在公立医院领着“官俸”,却已经拿到千万级“天使轮”的风险投资。 这种模式,也是当下非常热门的“体制内医生集团”——由一群来自于公立三甲大医院,“副主任”上下级别的医生自发组建。促使他们走到一起的共同特点,是年轻、有热情、有野心,不甘于在体制内循规蹈矩、论资排辈;但又不愿意放弃公立医院带来的大量患者、学术地位和稳

当今的互联网+创业潮中,风头正盛的,不得不说是医生集团。

一些医生集团的创始者,人还在公立医院领着“官俸”,却已经拿到千万级“天使轮”的风险投资。

这种模式,也是当下非常热门的“体制内医生集团”——由一群来自于公立三甲大医院,“副主任”上下级别的医生自发组建。促使他们走到一起的共同特点,是年轻、有热情、有野心,不甘于在体制内循规蹈矩、论资排辈;但又不愿意放弃公立医院带来的大量患者、学术地位和稳定的收益。

也难怪,在自由执业已成为中国医生“澎湃的心声”,而政府的医师执业政策还处于鼓励“多点执业”试点的大背景下,应运而生的“体制内医生集团”实际上是给自由多点执业加了一顶时尚的“礼帽”。

而资本也绝对精明,与其投资所谓的移动医疗,再去讨好公立大医院的医生,不如直接投资医生自己的“公司”。说白了,在线咨询、挂号也好,转战线下诊所也好,曾经在2014年还“大红大紫”的一众移动医疗公司,现在回头看,不过都是个技术平台。平台做得好,可以“去医院化”,为更多人提供优质的医疗服务。但优质医疗服务的提供者,归根到底,还是稀缺的医生。

这样看来,医生才是能在互联网+医疗的江湖中傲立潮头的“大佬”。

就在几个月前,苹果全新医疗应用researchkit后,惟一参与研发的中国医生——首都医科大学宣武医院神经内科副主任陈彪接受新京报记者采访时也坦言,“没有医生的参与,就不可能有真正的移动医疗。”

当然,伴随而来的,也有各种争议。最令人尴尬之处,是公立医院的医生属于事业单位在编人员甚至干部,而医生集团的目标是盈利。事业单位的在编干部不仅在外搞兼职,还成立了能够盈利,甚至可能营利的公司,不能不引人非议。

当然,对于还是“新生事物”的医生集团,盈利、甚至营利,都还是比较遥远的事情,“如何打造品牌、吸引患者、找到合适的执业地点,对医生集团现阶段的发展更为迫切”,一家最近以情怀抢尽眼球的体制内医生集团的一位核心创始人如是说。

毕竟,在这个绝大多数医生还不敢彻底走出体制,多点执业还与“飞刀”会诊厘不清道不明,患者看病还追着医院走的时代,医生集团还只是一个医生“自由执业”理想的雏形,需要合适的政策环境和市场环境孵化。

正如上海第一妇婴医院院长段涛的评论:几个人合伙,可以是工作室,也可叫“医生集团”;医院的前身,也是医生集团。医生集团要发展,至少满足四个要素:医生为主导、利益为纽带、合理的商业模式,有律师参与制定游戏规则。但在发展的轨道上,“医生集团”究竟是医生说了算、资本说了算,还是政府说了算,循环往复,看你处在哪个时代,哪个点上。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=57241, encodeId=125c5e24150, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57242, encodeId=79535e2424a, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57243, encodeId=fe735e243ef, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57238, encodeId=a9935e238c3, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57239, encodeId=218a5e23999, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57240, encodeId=fbe55e240a4, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274026, encodeId=42a512e4026ff, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438002, encodeId=7d9d14380021d, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620036, encodeId=c949162003616, content=<a href='/topic/show?id=ec5324125e3' target=_blank style='color:#2F92EE;'>#互联网+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24125, encryptionId=ec5324125e3, topicName=互联网+医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631320069238, createdName=yige2010, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2016-01-14 medsic

    嗯,好吧,

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=57241, encodeId=125c5e24150, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57242, encodeId=79535e2424a, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57243, encodeId=fe735e243ef, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57238, encodeId=a9935e238c3, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57239, encodeId=218a5e23999, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57240, encodeId=fbe55e240a4, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274026, encodeId=42a512e4026ff, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438002, encodeId=7d9d14380021d, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620036, encodeId=c949162003616, content=<a href='/topic/show?id=ec5324125e3' target=_blank style='color:#2F92EE;'>#互联网+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24125, encryptionId=ec5324125e3, topicName=互联网+医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631320069238, createdName=yige2010, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2016-01-14 medsic

    嗯,好吧,

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=57241, encodeId=125c5e24150, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57242, encodeId=79535e2424a, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57243, encodeId=fe735e243ef, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57238, encodeId=a9935e238c3, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57239, encodeId=218a5e23999, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57240, encodeId=fbe55e240a4, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274026, encodeId=42a512e4026ff, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438002, encodeId=7d9d14380021d, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620036, encodeId=c949162003616, content=<a href='/topic/show?id=ec5324125e3' target=_blank style='color:#2F92EE;'>#互联网+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24125, encryptionId=ec5324125e3, topicName=互联网+医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631320069238, createdName=yige2010, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2016-01-14 medsic

    嗯,好吧,

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=57241, encodeId=125c5e24150, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57242, encodeId=79535e2424a, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57243, encodeId=fe735e243ef, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57238, encodeId=a9935e238c3, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57239, encodeId=218a5e23999, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57240, encodeId=fbe55e240a4, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274026, encodeId=42a512e4026ff, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438002, encodeId=7d9d14380021d, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620036, encodeId=c949162003616, content=<a href='/topic/show?id=ec5324125e3' target=_blank style='color:#2F92EE;'>#互联网+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24125, encryptionId=ec5324125e3, topicName=互联网+医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631320069238, createdName=yige2010, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2016-01-14 medsic

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=57241, encodeId=125c5e24150, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57242, encodeId=79535e2424a, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57243, encodeId=fe735e243ef, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57238, encodeId=a9935e238c3, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57239, encodeId=218a5e23999, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57240, encodeId=fbe55e240a4, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274026, encodeId=42a512e4026ff, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438002, encodeId=7d9d14380021d, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620036, encodeId=c949162003616, content=<a href='/topic/show?id=ec5324125e3' target=_blank style='color:#2F92EE;'>#互联网+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24125, encryptionId=ec5324125e3, topicName=互联网+医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631320069238, createdName=yige2010, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2016-01-14 medsic

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=57241, encodeId=125c5e24150, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57242, encodeId=79535e2424a, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57243, encodeId=fe735e243ef, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57238, encodeId=a9935e238c3, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57239, encodeId=218a5e23999, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57240, encodeId=fbe55e240a4, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274026, encodeId=42a512e4026ff, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438002, encodeId=7d9d14380021d, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620036, encodeId=c949162003616, content=<a href='/topic/show?id=ec5324125e3' target=_blank style='color:#2F92EE;'>#互联网+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24125, encryptionId=ec5324125e3, topicName=互联网+医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631320069238, createdName=yige2010, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2016-01-14 medsic

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=57241, encodeId=125c5e24150, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57242, encodeId=79535e2424a, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57243, encodeId=fe735e243ef, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57238, encodeId=a9935e238c3, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57239, encodeId=218a5e23999, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57240, encodeId=fbe55e240a4, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274026, encodeId=42a512e4026ff, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438002, encodeId=7d9d14380021d, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620036, encodeId=c949162003616, content=<a href='/topic/show?id=ec5324125e3' target=_blank style='color:#2F92EE;'>#互联网+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24125, encryptionId=ec5324125e3, topicName=互联网+医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631320069238, createdName=yige2010, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=57241, encodeId=125c5e24150, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57242, encodeId=79535e2424a, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57243, encodeId=fe735e243ef, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57238, encodeId=a9935e238c3, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57239, encodeId=218a5e23999, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57240, encodeId=fbe55e240a4, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274026, encodeId=42a512e4026ff, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438002, encodeId=7d9d14380021d, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620036, encodeId=c949162003616, content=<a href='/topic/show?id=ec5324125e3' target=_blank style='color:#2F92EE;'>#互联网+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24125, encryptionId=ec5324125e3, topicName=互联网+医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631320069238, createdName=yige2010, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=57241, encodeId=125c5e24150, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57242, encodeId=79535e2424a, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57243, encodeId=fe735e243ef, content=嗯,好吧,, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:00:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57238, encodeId=a9935e238c3, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57239, encodeId=218a5e23999, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57240, encodeId=fbe55e240a4, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 12:59:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274026, encodeId=42a512e4026ff, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438002, encodeId=7d9d14380021d, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620036, encodeId=c949162003616, content=<a href='/topic/show?id=ec5324125e3' target=_blank style='color:#2F92EE;'>#互联网+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24125, encryptionId=ec5324125e3, topicName=互联网+医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631320069238, createdName=yige2010, createdTime=Fri Sep 18 05:17:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]

相关资讯

深圳成立华南首家“医生集团”

华南地区首家“医生集团”诞生了。深圳医生集团与来自北京的三甲医生集团、心血管医生集团昨日在深签约,组建深圳首家医生集团联盟“名医汇”,聚合深圳一流公办医院重点专科及医生。“名医汇”以俱乐部会员制为形式,通过开发互联网平台,为家庭包括老人小孩提供线上线下一条龙就医保健服务,可以实现“一人签约、全家受用、医生集团集体服务”,也意味着深圳医师多点执业有了实质突破。今年5月,深圳卫计委公布《医师执业注册和

中国很大三甲医生集团诞生

6月23日,健康微能量宣布,携手自有平台上两万名三甲医院医生,成立三甲医生集团。据悉,这是中国首个基于移动互联网且规模最大的三甲医院移动医生集团,覆盖北京、上海等全国顶尖的三甲医院的医生团队。不用离开医院,享受医生集团红利据了解,健康微能量推出的三甲医生集团,让体制内的医务工作者,无需离开医院,也能有更多发展的空间,实现个人价值最大化。三甲医院的医生,不用再纠结是否要辞职创业,完全可以安心在医院做

医生集团:滴滴医生是如何运转的?

越来越多的“医生集团”浮出水面,这与国家多点执业政策的逐步放开密切相关。2014年11月,国家卫计委和相关部门印发了《关于推进和规范医师多点执业的若干意见》。2014年12月,北京市实施了新版多点执业政策,取消了院长书面同意的审批环节和执业地点数量限制。其他地方,如浙江、广东等地的多点执业政策也陆续出台。 我们欣喜地发现,以“医生集团”的面貌出现的顶级医生们开始真正走向互联网。201

北京体制内医生集团获千万级规模投资 卫计委公开支持医生创业

奇点获悉,备受关注的北京“体制内医生集团”有了最近进展,初步获得投资机构千万级规模的投资。这是全国范围内首次获得巨额融资的医生集团。 医生集团合伙人之一、北京阜外医院孙宏涛表示,医生集团的名字叫做“大家医联”,这不是一个松散的平台,而是一个合伙制的公司,把志同道合创业的伙伴“绑”在一起。加入的医生既可以选择成为核心合伙人,也可以选择成为签约医生。 集团的医生来北京地区三甲医院,

中国医生集团火了,美国医生却开始返回医院,这是为啥?

最近国内医生集团的动静很大,给中国医生沉闷的职业发展路径添了一点点新意。反观医生集团模式非常成熟的美国,近几年来却有一些新动向:由于私人诊所的运行开支在不断上升,不少私人诊所的业务逐渐被大医院收购,一大批原来自由执业的医生开始返回医院,变身雇员。 根据美国医院协会的调查,与2001年相比,美国2011年直接受雇于医院的医生数量增加了30%~40%。2012年,美国医师协会特别进行了一项针

Baidu
map
Baidu
map
Baidu
map